The Democratic Republic of the Congo was one of the first African countries to acquire Africa's first research reactor. For many years, this facility has enabled the country to carry out research into plant improvement using radiation-induced mutations to solve the problems of food and nutritional insecurity. New varieties of maize with high levels of lysine and histidine were disseminated to the population. Later, the DRC used gamma rays emitted by the caesium-137 and cobalt-60 irradiators respectively to develop mutants of rice, groundnuts, soybean and maize. Radiation-induced mutations have also been associated with in vitro culture in the improvement of cassava and the production of secondary metabolites with biological activity for treating certain diseases such as malaria. But the challenges in this area remain even greater for the DRC, given the size of the country and the growth and poverty of its population.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Application of Gamma Radiation for the Genetic Improvement of Crop Plants in Democratic Republic of the Congo

  • Freddy Otono Bulubulu,
  • Bruno Munzemba Mbukula,
  • Victor Silulundi Matuta,
  • Moïse Itunga Muya,
  • Calvin Ciuma Ilunga,
  • Sébastien Ndiku Luyindula,
  • Jacques Ne Bambi Lutaladio,
  • Alexandre Ntumbula Mbaya,
  • Isaac Kofi Bimpong

摘要

The Democratic Republic of the Congo was one of the first African countries to acquire Africa's first research reactor. For many years, this facility has enabled the country to carry out research into plant improvement using radiation-induced mutations to solve the problems of food and nutritional insecurity. New varieties of maize with high levels of lysine and histidine were disseminated to the population. Later, the DRC used gamma rays emitted by the caesium-137 and cobalt-60 irradiators respectively to develop mutants of rice, groundnuts, soybean and maize. Radiation-induced mutations have also been associated with in vitro culture in the improvement of cassava and the production of secondary metabolites with biological activity for treating certain diseases such as malaria. But the challenges in this area remain even greater for the DRC, given the size of the country and the growth and poverty of its population.